Noom / Noom Med Cost Review: The First Payment Is Only Part of the Price

01Start by identifying which bill you are buying

Noom’s offerings fall into distinct purchasing categories. Noom Weight is its non-medication behavior-change subscription, featuring food and macro tracking, progress tracking, body scans, coaching and personalized lessons. The pricing page says it is also included with all medication plans. That inclusion makes the digital program part of the medication-plan price, but it does not make every Noom subscription a prescription service or establish that a prescription will be issued.

The medication-inclusive lineup includes Microdose GLP-1Rx, GLP-1Rx, GLP-1Rx Plus, Proactive Health GLP-1Rx and an oral metformin program. A different route, Telehealth for Branded Med, includes clinical care, a prescription when appropriate and the digital program, but excludes the drug’s purchase price. Comparing those two categories as though they were interchangeable monthly memberships would understate the branded route’s potential total cost.

The table summarizes the main pricing-page offers, not a verified personalized quote. For the GLP-1-branded bundles, the supplied documents do not establish the exact molecule, formulation, route and presentation for each tier. Program names alone cannot fill that gap. Our guide to what a program price includes provides a useful framework for separating clinical access, digital services and the actual medication.

02The monthly number is not necessarily the charge interval

The pricing page’s Microdose, GLP-1Rx, Plus and metformin offers all pair a lower starting payment with a higher ongoing monthly figure billed quarterly. An older Noom Med article explicitly says plans are billed upfront for three months after the introductory month. That article supports taking the collection interval seriously, but its older pricing should not override a current enrollment quote. Ask for the next charge amount and date, not just the monthly equivalent.

Proactive Health uses another structure: $149 every four weeks, with a first term of 15 weeks and renewal terms of 16 weeks. Noom says it includes home testing of 17 health biomarkers, clinical care, medication and its digital program, without requiring insurance. The description does not establish the quantity of medication supplied or fully explain how the four-week rate is collected across the unequal terms. Package duration alone is not proof of a minimum commitment.

Four weeks and a calendar month are different units, and a quarterly invoice is a separate concept again. The homepage adds a three-week introductory subscription alongside four weeks of medication, illustrating why service access and drug supply should be checked separately. Before paying, request a schedule showing subscription dates, medication coverage and renewal collection. The billing-cycle guide explains these distinctions without treating every advertised month as an identical purchasing period.

03Conflicting pages prevent a single definitive price

The homepage advertises an initial three-week subscription and four weeks of medication starting at $79 plus tax, followed by $199 per month plus tax for a 12-week subscription. Another homepage offer starts at $149 plus tax and then lists $349 per month plus tax for a 12-week subscription. Both restrict the new pricing to new accounts, effective March 31, 2026. The starting-at language and taxes are material conditions, not optional fine print.

Those figures differ from the pricing page’s $179 monthly Microdose renewal and $299 monthly Plus renewal. The supplied text does not prove that the homepage offers and pricing-page tiers are otherwise identical, so choosing the lower number would be unjustified. Noom describes Plus as acting on both GLP-1 and GIP receptors and including clinical care, medication and the digital program. That description still does not resolve the competing commercial terms or identify its exact preparation.

The Wegovy page creates a separate ambiguity by displaying both $39 initially followed by $129 per month and $69 initially followed by $99 per month for ongoing care; medication is excluded. The block does not explain which applicant receives which price. Likewise, the insurance checker promotes a first-month discount of $90 or more depending on program selection, while its starting-at-$39 subscription excludes medicine. None of these introductory figures establishes a universal renewal price.

04Insurance affects the medication bill, not every subscription

For branded medications, Noom says its telehealth service can help check potential insurance coverage. The medication is paid separately through insurance if approved or through cash payment, depending on the plan. Its pricing page says insurance does not cover the Noom program itself. Consequently, an insured prescription does not mean the subscription disappears, and buying the subscription does not establish that an insurer will cover the requested medicine.

The terms describe a different context for access through an employer or private health plan. Depending on that arrangement, independent clinical partners may submit claims, and clinical services may carry copays and deductibles. This is not necessarily inconsistent with the direct-purchase pricing page; it concerns another payment channel. Noom also states that it is not enrolled as a participating provider or vendor in federal or state healthcare programs, including Medicare and Medicaid.

Noom presents FSA/HSA reimbursement as possible rather than guaranteed, with requirements varying by program, plan and provider. Its insurance checker is informational: it does not initiate treatment requests or issue prescriptions. A useful budget therefore separates subscription charges, pharmacy charges and any applicable clinical cost sharing. Our insurance and self-pay guide explains the questions to put to each party before treating a coverage estimate as a payable benefit.

05Enrollment connects several parties, with different responsibilities

Noom describes enrollment as a short online assessment, an eligibility and plan review, and connection with a clinician it describes as licensed. It says pricing, subscription costs and next steps appear before commitment. Eligibility varies by program and may involve BMI, medical history and residence. The homepage excludes people under 18, pregnant people, people with an eating disorder and people who are underweight, defined there as a BMI below 18.5.

A Noom Med article updated in April 2025 gives BMI thresholds of at least 30, or at least 27 with a weight-related condition. That older description should not be treated as the criteria for every current offering. The Wegovy pathway also describes a metabolic laboratory test before online clinical evaluation, with a prescription only if clinically appropriate. The evidence does not establish which tests are required or included across all current tiers.

Noom, Inc. supplies the platform, while its terms assign medical and pharmacy services to independent partners. Coaches cannot diagnose or treat medical or mental health conditions, and coaching does not establish a physician-patient relationship. Noom advertises unlimited individual telehealth visits and clinician messaging, plus care-team help with insurance, fulfillment, refills and possible side effects. These are provider descriptions, not independent credential verification or a documented guarantee of a particular human response time.

06The pharmacy and delivery route can change the purchase

Noom’s homepage names Ozempic, Wegovy and Zepbound as possible prescriptions when a clinician considers them appropriate. A broader Noom Med article also lists Rybelsus, Mounjaro, Saxenda, Victoza, Trulicity, Contrave, metformin, topiramate and Bydureon. These are potential options, not a guarantee that every product is available to every member. Nor does a general medication list establish what drug is supplied within a particular medication-inclusive price.

The terms generally allow patients to choose a dispensing pharmacy, but preserve important exceptions. Some compounded prescriptions can be filled only by platform pharmacy partners. Certain generic programs require a preferred pharmacy to obtain that program and its price. The consulted material does not name the dispensing pharmacy for each tier or provide pharmacy-specific licensing details. A bundled price therefore needs a matching pharmacy-channel explanation before it can be meaningfully compared with a retail prescription.

The homepage advertises medication shipping in seven days, but does not clearly define the clock’s starting point or establish a universal arrival guarantee. It also says home delivery is unavailable for some medications and depends on insurance or cash-pay status. Current pricing warns that programs are not available in all 50 states; an older article excludes Alabama and Virginia. Neither statement supplies a current state-by-product matrix, so availability and delivery should be confirmed for the exact purchase.

07A bundled price does not establish product equivalence

Noom states that medications included in GLP-1Rx are produced in USP-compliant, state-regulated pharmacies and have not been reviewed by FDA for safety, efficacy or quality. Those are Noom’s descriptions, not an independent inspection. The supplied documents do not identify the exact molecule, formulation and route for each bundle. Its oral metformin offering is more explicit about route, and Noom acknowledges that metformin is not FDA-approved for weight loss.

FDA explains that compounded preparations are not FDA approved and do not undergo its premarket review for safety, effectiveness and quality. That distinction alone does not prove clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. This is a reason to clarify the prescribed preparation with the treating clinician, not to infer approval of Noom or its pharmacy partners.

FDA has also received reports of errors measuring or administering compounded medication, including some associated with hospitalization. Instructions belong with the prescriber or pharmacist, not a price comparison. For an injectable GLP-1 delivery that arrives warm or insufficiently refrigerated, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy. The reviewed Noom material does not establish detailed cold-chain, replacement or incident-resolution terms, leaving a meaningful practical question before payment.

08Renewal and refund rules deserve attention before care starts

Noom subscriptions renew automatically at the end of the disclosed billing period unless canceled as instructed. The terms require cancellation before 11:59 p.m. Eastern on the day before the next recurring billing date, with cancellation available through the account. They generally do not provide refunds or credits for partially used billing periods, although discretionary exceptions are possible. Stopping a future renewal and recovering an existing payment are therefore different requests.

The support refund policy distinguishes programs. For Noom Med, refunds may be available until a prescription has been written; afterward, that policy says refunds are no longer possible. Telehealth for Branded Meds instead allows potential refunds requested within seven days of the first charge, provided no clinical visit has occurred. The terms also describe a three-business-day rescission provision for California residents, so the support policy should not be read as eliminating every exception.

Another distinction concerns access after cancellation: support material says access continues through the cycle, while the terms allow immediate effect during a trial or promotion. Before enrolling, save the applicable offer, renewal date and refund terms, and ask which milestone changes refund eligibility. Our cancellation and refund guide explains why ending automatic billing should not be confused with reversing a charge or preserving access during an introductory period.

Questions & answers

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

1. FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
2. Noom / Noom Med — official website ↗
3. Noom / Noom Med — med/wegovy ↗
4. Noom / Noom Med — terms and conditions of use ↗
5. Noom / Noom Med — insurance checker ↗
6. Noom / Noom Med — blog/weight management/noom program/what is noom med and how much does it cost and what do you get ↗
7. Noom / Noom Med — support/faqs/subscription and billing/2025/10/noom refund policy ↗
8. Noom / Noom Med — med/pricing ↗

Continue reading

• Why Your First GLP-1 Payment Can Differ From the Advertised Monthly Price
• What a GLP-1 Program Price Actually Includes
• Monthly, Four-Week and Prepaid GLP-1 Billing Explained
• Insurance and Self-Pay: Questions Before Choosing a GLP-1 Program
• Canceling a GLP-1 Subscription: What Happens to the Money?